NM_000138.5:c.493C>T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000138.5(FBN1):c.493C>T(p.Arg165*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000138.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.493C>T | p.Arg165* | stop_gained | Exon 6 of 66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.493C>T | p.Arg165* | stop_gained | Exon 5 of 65 | NP_001393645.1 | ||
FBN1 | NM_001406717.1 | c.493C>T | p.Arg165* | stop_gained | Exon 6 of 9 | NP_001393646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.493C>T | p.Arg165* | stop_gained | Exon 6 of 66 | 1 | NM_000138.5 | ENSP00000325527.5 | ||
FBN1 | ENST00000559133.6 | n.493C>T | non_coding_transcript_exon_variant | Exon 6 of 67 | 1 | ENSP00000453958.2 | ||||
FBN1 | ENST00000537463.6 | n.493C>T | non_coding_transcript_exon_variant | Exon 6 of 31 | 5 | ENSP00000440294.2 | ||||
FBN1 | ENST00000674301.2 | n.493C>T | non_coding_transcript_exon_variant | Exon 6 of 68 | ENSP00000501333.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Marfan syndrome Pathogenic:2
The variant is not observed in the gnomAD v2.1.1 dataset. Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000042373). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
The Arg165X variant has previously been reported in 3 individuals with clinical features of Marfan syndrome (Rybczynski 2008, Rommel 2005, Soylen 2009). In addi tion, this variant has been identified in 3 other unrelated probands tested by o ur laboratory and cosegregates with clinical features in two families. This nons ense variant leads to a premature termination codon at position 165, which is pr edicted to lead to a truncated or absent protein. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM) bas ed upon predicted effect on the protein, presence in symptomatic individuals and segregation in symptomatic family members. -
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:2
- -
The p.R165* pathogenic mutation (also known as c.493C>T), located in coding exon 5 of the FBN1 gene, results from a C to T substitution at nucleotide position 493. This changes the amino acid from an arginine to a stop codon within coding exon 5. This alteration has been previously reported in individuals with clinical features of Marfan syndrome (Rommel K et al. Hum Mutat. 2005;26(6):529-39; Rybczynski M et al. Am J Med Genet. 2008;146A(24):3157-66; Söylen B et al. Clin Genet. 2009;75(3):265-70). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Isolated thoracic aortic aneurysm Pathogenic:1
- -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19012347, 25525159, 16220557, 25101912, 31279664, 31536524, 29357934, 33824467, 31098894, 19159394) -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg165*) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Marfan syndrome (PMID: 16220557, 19159394, 25101912). ClinVar contains an entry for this variant (Variation ID: 42373). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at